StonvexLoading…
StonvexStonvexStonvexCore line items from DCH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.38B | $5.84B | $4.45B | $2.95B |
Operating Income | $-33.70M | $112.30M | $146.10M | $97.70M |
Net Income | $-100.30M | $-19.70M | $55.60M | $46.40M |
EPS (Diluted) | $-0.52 | $-0.17 | $0.45 | $0.38 |
Total Assets | $11.27B | $6.67B | $5.34B | $5.27B |
Total Liabilities | $9.77B | $6.03B | $4.62B | $4.60B |
Cash & Equivalents | $1.01B | $708.90M | $714.10M | $586.50M |
Free Cash Flow OCF − CapEx | $-168.00M | $155.10M | $100.40M | $21.20M |
Shares Outstanding | 236.80M | 118.70M | 118.70M | 118.60M |